Relay Therapeutics Inc (NAS:RLAY)
$ 18.73 -1.27 (-6.35%) Market Cap: 4.08 Bil Enterprise Value: 3.47 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 58/100

Relay Therapeutics Inc Conference Call Transcript

May 19, 2026 / 12:00PM GMT
Release Date Price: $12.07 (-0.25%)
Operator

Good day, ladies and gentlemen. Welcome to Relay Therapeutics Vascular Anomalies update call. As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Mr. Pete Rahmer, Chief Corporate Development Officer at Relay Therapeutics. Sir, you may begin.

Peter Rahmer
Relay Therapeutics Inc - Chief Corporate Development Officer

Thank you, operator, and good morning, everyone. Thanks for joining us. We are very excited to share our initial vascular anomalies data with you today. You can access the press release from today. The slides we are reviewing and a replay of this call by going to the Investor Relations section of our website.

As a reminder, during this call, we will make certain statements that are considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including expressed or implied statements regarding our strategy, business plans and objectives, and expected therapeutic and clinical benefits of our product candidates, potential of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot